AtG Therapeutics — Seed (estimated) · €556K

AtG Therapeutics, a spin-off of IDIBELL and the Catalan Institute of Oncology founded by researchers Oriol Casanovas and Gabriela Jiménez, closed its first financing round of €556,000 to build a portfolio of drugs for advanced renal, colorectal and breast cancers. No lead was named; Boston-based Blue Goose Capital invested alongside two business angel groups, WA4STEAM and StapleCat/Inveniam, plus several international scientists.